ClinicalTrials.gov
public full text
Public Domain
Prevention of Maternal-fetal Cytomegalovirus Transmission After Primary Maternal Infection, GW ≤ 14 (PreCyssion)
A phase 3, open-label, single-arm, prospective, multi-center trial of Cytotect CP Biotest (BT097) for prevention of maternal-fetal CMV transmission after primary maternal CMV infection. The main purpose of the trial is to demonstrate efficacy and safety of Cytotect CP Biotest in preventing maternal-fetal transmission of cytomegalovirus (CMV).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Maternal Antibodies to Primary CMV Infection Link to Fetal Transmission#1306425
- Study of the Transmission of Cytomegalovirus (CMV) Infection From Mother to Foetus#919111
- The Epidemiologic Study of Human Cytomegalovirus（CMV） in Female Students of Xiamen University#1171720
- HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial#914968
- Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates#245559
Record · ID 1211370
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive